Quickly getting a new therapeutic product into major markets requires a global clinical development program with multinational clinical studies. Careful central planning avoids duplication of development steps, while complying with local regulations and international standards for the quality of data and reporting. PharmaNet Consulting professionals provide the expertise you need to design an efficient program that will satisfy local regulatory requirements, while maximizing both labeling claims and geographic distribution of your product.
PharmaNet professionals available for consultation on this topic include:
Executive Director, PharmaNet Consulting
Executive Director, PharmaNet Consulting
Senior Vice President, PharmaNet Consulting
Joyce Lea Frey-Vasconcells, PhD
Executive Director, PharmaNet Consulting
Senior Vice President, Regulatory Affairs Worldwide
Executive Vice President, Biostatistics
Vice President, Scientific and Regulatory Affairs, Anapharm
Executive Director, PharmaNet Consulting
504 Carnegie Center, Princeton, NJ 08540